Shenoy Niraj, Dronca Roxana, Quevedo Fernando, Boorjian Stephen A, Cheville John, Costello Brian, Kohli Manish, Witzig Thomas, Pagliaro Lance
Division of Oncology, Mayo Clinic, Rochester, MN 55905, USA.
Chin J Cancer Res. 2017 Aug;29(4):374-378. doi: 10.21147/j.issn.1000-9604.2017.04.11.
The molecular basis for enhanced chemosensitivity of testicular germ cell tumors (GCT) has been an area of great interest, as it could potentially give us therapeutic leads in other resistant malignancies. Thus far, however, the increased sensitivity of GCT has been variously attributed to multiple factors - an inability to detoxify cisplatin, a lack of export pumps, an inability to repair the DNA damage, an intact apoptotic cascade and lack of p53 mutation; but a unifying underlying etiology leading to the aforementioned processes and having a translational implication has so far been elusive. Herein, we offer evidence to support a potential significant role for the previously demonstrated low hypoxia inducible factor-1α (HIF-1α) expression in mediating the general exquisite chemosensitivity of testicular GCT, through the aforementioned processes. This molecular mechanism based hypothesis could have a significant translational implication in platinum refractory GCT as well as other platinum resistant malignancies.
睾丸生殖细胞肿瘤(GCT)化疗敏感性增强的分子基础一直是备受关注的领域,因为它可能为我们提供针对其他耐药性恶性肿瘤的治疗线索。然而,迄今为止,GCT敏感性增加的原因被归因于多种因素——无法使顺铂解毒、缺乏输出泵、无法修复DNA损伤、凋亡级联完整以及缺乏p53突变;但导致上述过程并具有转化意义的统一潜在病因迄今仍不明确。在此,我们提供证据支持先前证明的低缺氧诱导因子-1α(HIF-1α)表达在通过上述过程介导睾丸GCT普遍的高化疗敏感性中发挥潜在的重要作用。这种基于分子机制的假说可能对铂难治性GCT以及其他铂耐药性恶性肿瘤具有重要的转化意义。